Appia Bio

Appia Bio

Appia Bio is a biotechnology startup dedicated to discovering and developing scalable allogeneic cell therapies to increase access to cancer treatment. Market:Cell therapy has brought dramatic improvements in efficacy and durable remission rates in certain...
InSpira

InSpira

InSpira is focused on the development of breakthrough treatments and, ultimately, a cure for pulmonary fibrosis and other fibrotic diseases. Market:Idiopathic Pulmonary Fibrosis (IPF) is a chronic and ultimately fatal disease characterized by a progressive decline in...
MyoGene Bio

MyoGene Bio

MyoGene Bio is developing cutting edge therapeutics for muscle diseases, starting with a gene editing therapy for Duchenne muscular dystrophy. Market:Duchenne muscular dystrophy (DMD) is a severe, progressive muscle wasting disorder that affects approximately 1 in...
Myst Therapeutics

Myst Therapeutics

Myst Therapeutics, Inc. is developing novel cancer immunotherapy products designed to harness the power of a patient’s own immune system to destroy solid tumor cancer cells. Market:Over 400,000 Americans die from cancer every year, with roughly 10% being blood cancers...
Scarless Laboratories

Scarless Laboratories

Scarless Laboratories is an early-stage biotechnology company with a mission to develop safe and effective therapies for scar minimization and wound healing. Market:There are no approved drug-based therapies for improvement in scar appearance, wound tensile strength...